CompuMed

CompuMed Stock-Based Compensation

Stock-Based Compensation (SBC) of CompuMed (CMPD) as of Nov 22, 2026.

Stock-Based Compensation

-USD

Last updated:

Stock-Based Compensation (SBC) of CompuMed is 2026 - USD. Stock-Based Compensation (SBC) of CompuMed was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CompuMed Stock analysis

What does CompuMed do? CompuMed Inc., based in Los Angeles, US, provides enterprise telemedicine solutions specializing in telecardiology and teleradiology. The company offers cloud-based access to U.S. Board-Certified specialists for diagnosing cardiovascular diseases and osteoporosis, utilizing integrated medical devices such as GE MAC 1200 ECG equipment and GE Vscan ultrasound devices. Its network processes ECGs, echocardiograms, ultrasounds, and X-rays remotely, connecting point-of-care diagnostic data with specialists via a centralized call center. CompuMed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CompuMed stock

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) CompuMed since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s CompuMed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — CompuMed

All Key Metrics — CompuMed